Literature DB >> 33627196

Myogenic progenitor cell transplantation for muscle regeneration following hindlimb ischemia and reperfusion.

Franka Messner1, Marco Thurner1,2, Stefan Schneeberger3,4, Theresa Hautz5, Jule Müller1, Michael Blumer6, Julia Hofmann1, Rainer Marksteiner2, Sebastien Couillard-Despres7,8, Jakob Troppmair1, Dietmar Öfner1.   

Abstract

BACKGROUND: Muscle is severely affected by ischemia/reperfusion injury (IRI). Quiescent satellite cells differentiating into myogenic progenitor cells (MPC) possess a remarkable regenerative potential. We herein established a model of local application of MPC in murine hindlimb ischemia/reperfusion to study cell engraftment and differentiation required for muscle regeneration.
METHODS: A clamping model of murine (C57b/6 J) hindlimb ischemia was established to induce IRI in skeletal muscle. After 2 h (h) warm ischemic time (WIT) and reperfusion, reporter protein expressing MPC (TdTomato or Luci-GFP, 1 × 106 cells) obtained from isolated satellite cells were injected intramuscularly. Surface marker expression and differentiation potential of MPC were analyzed in vitro by flow cytometry and differentiation assay. In vivo bioluminescence imaging and histopathologic evaluation of biopsies were performed to quantify cell fate, engraftment and regeneration.
RESULTS: 2h WIT induced severe IRI on muscle, and muscle fiber regeneration as per histopathology within 14 days after injury. Bioluminescence in vivo imaging demonstrated reporter protein signals of MPC in 2h WIT animals and controls over the study period (75 days). Bioluminescence signals were detected at the injection site and increased over time. TdTomato expressing MPC and myofibers were visible in host tissue on postoperative days 2 and 14, respectively, suggesting that injected MPC differentiated into muscle fibers. Higher reporter protein signals were found after 2h WIT compared to controls without ischemia, indicative for enhanced growth and/or engraftment of MPC injected into IRI-affected muscle antagonizing muscle damage caused by IRI.
CONCLUSION: WIT-induced IRI in muscle requests increased numbers of injected MPC to engraft and persist, suggesting a possible rational for cell therapy to antagonize IRI. Further investigations are needed to evaluate the regenerative capacity and therapeutic advantage of MPC in the setting of ischemic limb injury.

Entities:  

Keywords:  Ischemia-reperfusion injury; Muscle regeneration; Myogenic progenitor cells; Satellite cells; Stem cell; Transplantation

Year:  2021        PMID: 33627196      PMCID: PMC7905585          DOI: 10.1186/s13287-021-02208-w

Source DB:  PubMed          Journal:  Stem Cell Res Ther        ISSN: 1757-6512            Impact factor:   6.832


  38 in total

1.  Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury.

Authors:  Mark A LaBarge; Helen M Blau
Journal:  Cell       Date:  2002-11-15       Impact factor: 41.582

2.  Transplanted myoblasts can migrate several millimeters to fuse with damaged myofibers in nonhuman primate skeletal muscle.

Authors:  Daniel Skuk; Marlyne Goulet; Jacques P Tremblay
Journal:  J Neuropathol Exp Neurol       Date:  2011-09       Impact factor: 3.685

Review 3.  Ischemia/reperfusion injury in vascularized tissue allotransplantation: tissue damage and clinical relevance.

Authors:  Franka Messner; Johanna Grahammer; Theresa Hautz; Gerald Brandacher; Stefan Schneeberger
Journal:  Curr Opin Organ Transplant       Date:  2016-10       Impact factor: 2.640

Review 4.  Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials.

Authors:  S M O Peeters Weem; M Teraa; G J de Borst; M C Verhaar; F L Moll
Journal:  Eur J Vasc Endovasc Surg       Date:  2015-10-12       Impact factor: 7.069

5.  Efficacy of myoblast transplantation in nonhuman primates following simple intramuscular cell injections: toward defining strategies applicable to humans.

Authors:  Daniel Skuk; Marlyne Goulet; Brigitte Roy; Jacques P Tremblay
Journal:  Exp Neurol       Date:  2002-05       Impact factor: 5.330

6.  First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up.

Authors:  Daniel Skuk; Marlyne Goulet; Brigitte Roy; Vincent Piette; Claude H Côté; Pierre Chapdelaine; Jean-Yves Hogrel; Martin Paradis; Jean-Pierre Bouchard; Michel Sylvain; Jean-Guy Lachance; Jacques P Tremblay
Journal:  Neuromuscul Disord       Date:  2006-12-04       Impact factor: 4.296

7.  High-resolution myogenic lineage mapping by single-cell mass cytometry.

Authors:  Ermelinda Porpiglia; Nikolay Samusik; Andrew Tri Van Ho; Benjamin D Cosgrove; Thach Mai; Kara L Davis; Astraea Jager; Garry P Nolan; Sean C Bendall; Wendy J Fantl; Helen M Blau
Journal:  Nat Cell Biol       Date:  2017-04-17       Impact factor: 28.824

8.  Autologous skeletal-muscle-derived cell injection for anal incontinence due to obstetric trauma: a 5-year follow-up of an initial study of 10 patients.

Authors:  A Frudinger; J Pfeifer; J Paede; V Kolovetsiou-Kreiner; R Marksteiner; S Halligan
Journal:  Colorectal Dis       Date:  2015-09       Impact factor: 3.788

9.  Aberrant repair and fibrosis development in skeletal muscle.

Authors:  Christopher J Mann; Eusebio Perdiguero; Antonio L Serrano; Yacine Kharraz; Susana Aguilar; Patrizia Pessina; Pura Muñoz-Cánoves
Journal:  Skelet Muscle       Date:  2011-05-04       Impact factor: 4.912

10.  Sex differences in primary muscle afferent sensitization following ischemia and reperfusion injury.

Authors:  Jessica L Ross; Luis F Queme; Jordan E Lamb; Kathryn J Green; Michael P Jankowski
Journal:  Biol Sex Differ       Date:  2018-01-03       Impact factor: 5.027

View more
  2 in total

1.  Therapeutic potential of mesenchymal stem cells for peripheral artery disease in a rat model of hindlimb ischemia.

Authors:  Amani M El Amin Ali; Amira S Ahmed; Dina F El-Yasergy; Moustafa A Abousarie; Ramadan M Elsayed; Yasmin E Mohammed; Rahab A Mohammed
Journal:  Iran J Basic Med Sci       Date:  2021-06       Impact factor: 2.699

Review 2.  Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: Clinical experience and experimental implications.

Authors:  Jiqiang He; Umar Zeb Khan; Liming Qing; Panfeng Wu; Juyu Tang
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.